Current status of controlled onco-therapies based on metal organic frameworks

Area of Science:

• Nanotechnology and Materials Science
• Oncology and Cancer Therapeutics
• Drug Delivery Systems

Background:

• Cancer remains a significant global health challenge despite ongoing therapeutic advancements.
• Controlled drug release systems are crucial for enhancing the efficacy of cancer treatments.
• Nanotechnology offers innovative solutions for developing advanced drug delivery platforms.

Purpose of the Study:

• To review the potential of Metal-Organic Frameworks (MOFs) as drug delivery vehicles for cancer therapy.
• To classify MOFs based on their suitability for controlled anti-cancer drug release.
• To identify current strategies and future opportunities for MOF-based cancer treatments.

Main Methods:

• Comprehensive literature review of MOFs in oncology and drug delivery.
• Analysis of chemical and physical properties of MOFs relevant to anti-cancer applications.
• Classification of MOFs into six categories based on their therapeutic potential.
• Examination of existing strategies for MOF-based controlled drug release.

Main Results:

• MOFs possess unique porous structures and large loading capacities, making them ideal for drug delivery.
• Stimuli-sensitive components can be incorporated into MOFs to create targeted and controlled anti-cancer therapeutics.
• Six distinct categories of MOFs suitable for controlled anti-cancer modalities were identified.
• Current strategies for utilizing these MOFs in cancer treatment were outlined.

Conclusions:

• MOFs represent a highly promising class of nanomaterials for developing advanced, controlled anti-cancer drug delivery systems.
• Further research into MOF design and application can lead to improved and expanded clinical oncology treatments.
• Identifying understudied areas will drive innovation in MOF-based cancer therapeutics.